Drug 'Zocor', umarnin don amfani, da data na binciken kiwon lafiya

"Zocor" - wani magani alaka asibiti da kuma pharmacological kungiyar hypolipidemic kwayoyi. The aiki wakili halitta "Zocor" - simvastin, daya kwamfutar hannu iya ƙunsar 10,20, da kuma 40 MG, kazalika da karin: ascorbic da kuma citric acid, butylhydroxyanisole, talc, magnesium stearate da sauransu.

'Zocor' ne mai matuƙar tasiri, har suka sa a general akan rage cholesterol a cikin jiki. Wannan yana da muhimmanci musamman a cikin wani gauraye hyperlipidemia, saboda da ganewar asali na ta ƙara abun ciki da aka dauke da wani hadarin factor. Na tsawon makonni 2 ne zai yiwu a cimma wata m m kuzarin kawo cikas, da warkewa sakamako aka sa a matsakaicin matakin for 4 - 6 makonni. cholesterol ne koma ga na farko saitin lokacin da ka dakatar da magani tare da 'Zocor', umurci manual ƙunshi wasu bincike kan magunguna bayanai.

Kulawa da marasa lafiya a cikin wani adadin game 4.5 dubu. Man aka sanya don 5.4 shekaru. A duk binciken da ya lura cholesterol (MG / dl.), 212 - 309. Yanayin aiki "Zocor" 30% rage hadarin mace-mace, da yawan tsokar zuciya infarction ta 37% (lokuta tabbatar a asibiti saituna), 42% - mutuwa daga CHD. A wani 37-haƙuri daga 100 babu bukatar tiyata don daidaita jijiyoyin zuciya jini ya kwarara.

A Birtaniya, 5.5 shekaru surveyed marasa lafiya (20536 mutane) wanda ya gani ko ya annabta CHD. A cikin uku na binciken hadarin shanyewar jiki da kuma zuciya harin da aka rage zuwa m. Tare da cewa, da farko cholesterol matakin, a layi daya to warkewa magani, jima'i da kuma shekaru na marasa lafiya ba zai shafi yadda ya dace da shan miyagun ƙwayoyi "Zocor". Umarnin don amfani da cikakken kwatanci ta pharmacokinetics, kafin su shiga cikin jini shi ne tunawa daga cikin gastrointestinal fili. An gwaje nuna simvastina high jari a cikin hanta da kuma a cikin sauran gabobin na taro samu a yawa karami yawa, da aiki abu aka samu daga bile.

Ischemic cuta na zuciya shi ne babban nuni ga miyagun ƙwayoyi "Zocor", umarnin don amfani da nufin yin amfani da wasu daga cikin kwallaye:

- wani m awo da ciwon zuciya.

- inda hakan ya saukar da aiwatar da jijiyoyin zuciya atherosclerosis;

- karfafawa bugun jini, bugun jini rage haɗarin.

Lokacin da dagagge matakan cholesterol da miyagun ƙwayoyi "Zocor" na taimaka wa ta rage da kuma ineffectiveness warkewa abun da ake ci, kazalika da sauran wadanda ba pharmacological matakan kamar lokacin da hypercholesterolemia ci gaba a cikin wani hadarin factor, shi ne ya dace da cewa saduwa lekartsvennogo wajen.

A cikin m mataki hanta gazawar nufin da contraindication ga gwamnati da miyagun ƙwayoyi "Zocor". Umurnai na amfani ne kuma ba da shawarar yin amfani da miyagun ƙwayoyi a lokacin daukar ciki ko shayarwa, kazalika ganewa na hypersensitivity da miyagun ƙwayoyi.

"Zocor" Yanã wasu illa na narkewa kamar tsarin. Duk da yake shan miyagun ƙwayoyi "Zocor", da sanarwar da maki to zai yiwu maƙarƙashiya, ciki zafi, akwai bayani a kan lokuta na hepatitis, pancreatitis, jaundice.

Side effects lura tare da girmamawa ga tsakiya m tsarin, wannan tsoka cramps, juwa ko jiri, na gefe neuropathy.

Da wuya, amma rashin lafiyan halayen faruwa kamar yadda angioedema, vasculitis, volchanochnopodobnogo ciwo, amosanin gabbai, ta ƙara ESR, zazzabi, dyspnea, eosinophilia.

A lokuta da yawan abin sama da aka samu mummunan gefen bayyananen dauke soma iyakar kashi na 450 MG.

Store miyagun ƙwayoyi "Zocor" shawarar t max digiri 30, ko da wucin gadi daukan hotuna t game da 50 digiri kamata a kauce masa.